Update on the management of chemotherapy-induced nausea and vomiting – focus on palonosetron

PURPOSE: Nausea and vomiting are major adverse effects of chemotherapy and can greatly impact patients’ quality of life. Although chemotherapy-induced nausea and vomiting (CINV) prevalence is high, treatment remains difficult. Palonosetron is a 5-hydroxytryptamine receptor antagonist (5-HT(3)RA) app...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Michelle, Popovic, Marko, Pasetka, Mark, Pulenzas, Natalie, Ahrari, Soha, Chow, Edward, DeAngelis, Carlo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4435088/
https://www.ncbi.nlm.nih.gov/pubmed/25999723
http://dx.doi.org/10.2147/TCRM.S68130

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4435088/
https://www.ncbi.nlm.nih.gov/pubmed/25999723
http://dx.doi.org/10.2147/TCRM.S68130

Ejemplares similares